Immune Repertoire Decoding

February 8 and  9, 2023
Time: TBD
Registration Opening Soon!

Summary

February 8-9, 2023

Leading experts will introduce the audience to recent advances in decoding the specific T cell clonotypes mediating or protecting from disease along with their recognized antigen epitopes in the context of human HLA haplotypes. This information promises to enable next generation T cell clonotype or epitope targeted immunotherapies for cancer, autoimmune or infectious diseases that are both more efficacious and safer than current therapies. Recent advances in single cell sequencing technologies and large-scale HLA tetramer or HLA reporter gene-based epitope library screening technologies have made decoding the "immune synapse" possible.

Organizers: Karsten Sauer, PhD, Vice President, Pre-clinical Research and Development, Cullinan Oncology, Michael Birnbaum, PhD, Associate Professor, Massachusetts Institute of Technology, Cambridge

Registration Fee: $25

Presenters: Catherine Bollard, Children’s National Hospital, Anthony Coyle, Repertoire Immune Medicines, Stephen Elledge, Harvard University, Claude Perreault, University of Montreal, Ivelin Georgiev, Vanderbilt University, Jenny Jiang, University of Pennsylvania, Alessandro Sette, La Jolla Institute for Immunology, Anish Suri, Cue Biopharma, and Mark Yarmarkovich, University of Pennsylvania.

Program

Additional information, including registration and the conference agenda will be available in the next few months.


 

Presenters